LeMaitre Vascular Announces Q2 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
Lemaitre Vascular (LMAT) Tops Q2 EPS by 2c, Revenues Beat; Offers Q3 & FY19 EPS/Revenue Guidance Above Consensus
July 24, 2019 4:43 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $29.5 million versus the consensus estimate of $28.9 million.
Record sales of $29.5mm, +9% (+5% organic) vs. Q2 2018Operating income of $5.9mm vs. $11.5mm,... More